About MarketingInsights

This author has not yet filled in any details.
So far has created 110 blog entries.

CSI Specialty Group Named One of 2017’s Top Women-Led Businesses in Florida

May 18th, 2017|

The Commonwealth Institute (TCI) of South Florida has named CSI Specialty Group (CSI), led by President and CEO Suzette DiMascio CHE, CMCE, CPC, among the Top Women-Led Business in Florida for 2017.

Each year, TCI collaborates with Kaufman Rossin to conduct a survey of women-led businesses to determine the top 50 women-led for-profit organizations and the […]

NASP Has Had Enough of DIR Fees

May 11th, 2017|

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, regularly publishes industry articles on LinkedIn. Visit the CSI LinkedIn page and read the full articles by clicking here.

A recent comment by PCMA’s CEO, Mark Merritt, prompted a shot across the bough on Direct and Indirect Remuneration Fees plaguing the industry right now.

NASP […]

Journal of Managed Care & Specialty Pharmacy Out Now

May 5th, 2017|

Recently, Suzette DiMascio, CHE, CMCE, CPC, President/CEO of CSI Specialty Group, was selected to be part of a team of hand selected healthcare executives brought together to advance value-based reimbursement in oncology at the Academy of Managed Care Pharmacy (AMCP) Partnership Forum: Driving Value and Outcomes in Oncology.

The partnership forum, held last fall, focused on the need […]

Ep. 53 – How Continued Training Contributes to Specialty Pharmacy Success (and How CSI University Can Help)

May 3rd, 2017|

John Hafl, Senior Vice President, Sales

In this episode, hosting duties belong to at CSI Specialty Group, and Brian Maxin, Sales Manager for CSI Specialty Group. The two sales gurus discuss how continued training contributes to specialty pharmacy success and how a tool like CSI University’s continued online education modules can help foster […]

Ep. 52 – Announcing a Can’t Miss Online Training Platform Launching at Asembia’s 2017 Specialty Pharmacy Summit

April 19th, 2017|

In this episode, host Suzette DiMascio, CHE, CMCE, CPC, President and CEO of CSI Specialty Group, shares a few tips you’ll need to make the most out of Asembia’s 2017 Specialty Pharmacy Summit before turning the reins over to John Hafl, Senior Vice President of Sales at CSI Specialty Group, to announce the launch of […]

CSI President and CEO Appointed to National Medication Advisory Panel

April 10th, 2017|

CSI Specialty Group has announced the appointment of CSI President and CEO Suzette DiMascio, CHE, CMCE, CPC, to the National Stakeholder Advisory Panel of the Pharmacy Quality Alliance (PQA).

“We are proud to be part of such a credible and committed national body, dedicated to improving healthcare quality and patient safety as they relate to the […]

Ep. 51 An Interview with the CEO of One of the Leading Rare and Orphan Disease Specialty Pharmacies in the U.S.

April 5th, 2017|

This episode is part of our Expert Interview Series. In each episode of this series, we’ll interview industry professionals for their perspective on the evolving specialty pharmacy market.

Dr. Gordon Vanscoy, Chairman and CEO of PANTHERx

In this episode, Dr. Gordon Vanscoy, Chairman and CEO of PANTHERx, joins host Suzette DiMascio, CHE, CMCE, […]

Now Available: 2017 State of Specialty Pharmacy Report

March 27th, 2017|

The 2017 State of Specialty Pharmacy Report is now available to download for free at CSIgroup.net/Survey.

The annual report is a compilation of survey responses from specialty pharmacy professionals of all levels across all specialties to help discover and identify trends, opinions and predictions for the future of the special pharmacy industry.

Within the 72 page report, […]

Ep. 50 CSI to Release 2017 State of Specialty Pharmacy Report

March 23rd, 2017|

On March 27, 2017, at the Academy of Managed Care Pharmacy (AMCP) Conference in Denver, CO, CSI Specialty Group will release its inaugural edition of the 2017 State of Specialty Pharmacy Report. This annual report is a compilation of survey responses from specialty pharmacy professionals of all levels across all channels to help identify current trends, […]

Ep. 49 Why You Need to Support House Bill HR 1316

March 8th, 2017|

On March 2, 2017, the House of Representatives proposed a new bipartisan bill, known as the Prescription Drug Price Transparency Act (Bill HR 1316), requiring PBMs to disclose pricing information and create the first act of legislation in U.S. history for transparency. What does this mean for you and what kind of precedent does it […]